Medical Global Academy

August 18, 2026

Pathologists comparing subspecialties to choose between a fellowship in molecular pathology and cytopathology
Learning blogs

Fellowship in Molecular Pathology vs Cytopathology: Choosing a Diagnostic Subspecialty

Quick Answer Molecular pathology and cytopathology are both diagnostic subspecialties within pathology, but they involve fundamentally different daily work. Molecular pathology centres on nucleic acid-based testing — PCR, sequencing, biomarker analysis — that informs targeted therapy and precise disease classification, often performed at the bench with limited direct patient contact. Cytopathology centres on interpreting cellular samples — FNAC, exfoliative cytology, effusion fluids — often with same-day, rapid-turnaround reporting and, in many practices, direct involvement in performing the aspiration itself. Choose based on which kind of diagnostic work suits your interest and the kind of laboratory or hospital setting you want to build a career in — not on which sounds more advanced. Every MD Pathology or DNB Pathology holder eventually faces a subspecialty fork. General diagnostic pathology gives broad competence, but career depth and consultant-level differentiation increasingly come from a defined subspecialty focus. Two of the most commercially and clinically relevant options are molecular pathology and cytopathology — and they are frequently confused as adjacent when they are, in practice, quite different disciplines. This article compares MGA’s Fellowship in Molecular Pathology and Fellowship in Cytopathology directly — what each subspecialty actually involves day to day, what skill set each builds, and which one is the better fit depending on your existing practice and career direction. If you are still evaluating pathology as a specialty more broadly, our Fellowship in Pathology overview is the right starting point before narrowing to a subspecialty. 2 paths Distinct diagnostic subspecialties compared Bench vs bedside Core practice difference 1 year Typical fellowship duration What this guide covers What the Fellowship in Molecular Pathology covers What the Fellowship in Cytopathology covers Direct comparison: daily practice, skills, and career settings Who should choose molecular pathology Who should choose cytopathology Can you build competency in both? Frequently asked questions What the Fellowship in Molecular Pathology covers Molecular pathology is the diagnostic discipline concerned with detecting disease at the level of nucleic acids and molecular biomarkers rather than tissue architecture or cell morphology alone. It has become central to modern oncology, infectious disease diagnostics, and inherited disease testing because treatment decisions increasingly depend on molecular characterisation rather than histological appearance alone. Core content areas Molecular techniques and principles: Polymerase chain reaction (PCR) and its variants, nucleic acid extraction, Sanger sequencing, and the principles of next-generation sequencing (NGS) form the technical foundation. Understanding how these techniques work — not just what they report — is what allows a pathologist to interpret results critically rather than simply transcribe them. Molecular oncology: Biomarker testing that guides targeted cancer therapy — EGFR, ALK, KRAS, BRCA, and similar actionable mutations — along with the tumour classification systems that increasingly integrate molecular findings alongside histology. This is the area of molecular pathology with the most direct clinical impact on treatment selection. Molecular infectious disease diagnostics: PCR-based pathogen detection, viral load quantification, and resistance testing — applications that have expanded substantially in Indian laboratories following increased demand for rapid, sensitive infectious disease diagnostics. Inherited disease and genetic testing principles: The basis of testing for inherited conditions, carrier screening principles, and the interpretation framework for genetic variants — foundational knowledge relevant to laboratories offering genetic testing services. Quality assurance and test validation: Molecular testing carries specific quality assurance requirements — assay validation, proficiency testing, and result reporting standards — that differ substantially from morphology-based diagnostic work. This is a curriculum area with direct laboratory management relevance. What the daily work looks like Molecular pathology practice is largely laboratory- and bench-based. The pathologist’s role centres on test selection, result interpretation in clinical context, and quality oversight of the molecular testing process — with limited direct patient contact compared to procedural diagnostic disciplines. It suits doctors who are drawn to the technical and interpretive precision of nucleic acid-based diagnostics. View the Fellowship in Molecular Pathology CPD accredited · Evening classes after OPD · Eligible doctors View Program What the Fellowship in Cytopathology covers Cytopathology is the diagnostic discipline concerned with interpreting individual cells and small cell clusters obtained from fluid samples, scrapings, or fine needle aspiration — rather than the tissue architecture examined in histopathology. It is one of the most immediately clinically applied pathology subspecialties, frequently involving rapid, same-visit diagnostic decisions. Core content areas Fine needle aspiration cytology (FNAC): Technique and interpretation for aspirating and evaluating superficial masses — thyroid nodules, lymph nodes, breast lumps, and salivary gland masses are the most common. FNAC training covers both the aspiration technique itself and the cytological interpretation of the resulting sample. Gynecological cytology: Cervical cytology screening and interpretation, including the recognition of pre-malignant and malignant cervical changes — a high-volume diagnostic area with direct population health relevance in cervical cancer screening programmes. Non-gynecological exfoliative cytology: Interpretation of cells shed into body fluids — sputum, urine, pleural and peritoneal effusions, and cerebrospinal fluid. This is a substantial component of general cytopathology practice, particularly in the evaluation of effusions for malignancy. Rapid on-site evaluation principles: The practice of assessing specimen adequacy at the time of collection — a skill that directly reduces the need for repeat procedures and speeds diagnostic turnaround, particularly relevant when aspirations are image-guided. Ancillary technique correlation: Understanding how immunocytochemistry and, where relevant, molecular testing on cytology specimens integrate with cytomorphological interpretation to reach a definitive diagnosis. What the daily work looks like Cytopathology combines interpretive laboratory work with, depending on practice setting, direct involvement in specimen collection through FNAC. Reporting turnaround is frequently rapid — same-day or next-day in many settings — and the diagnostic reasoning is built around recognising cellular patterns rather than tissue architecture. It suits doctors who want a subspecialty with both a procedural and interpretive dimension. View the Fellowship in Cytopathology CPD accredited · Evening classes after OPD · Eligible doctors View Program Direct comparison: molecular pathology vs cytopathology Factor Molecular Pathology Cytopathology Core diagnostic basis Nucleic acids, biomarkers, molecular alterations Cellular morphology in fluid and aspirate samples Patient contact Minimal — primarily bench and interpretive work Variable — FNAC often involves direct

Pathologist reviewing a whole slide image on a screen representing digital pathology in India
Learning blogs

Digital Pathology and AI-Assisted Diagnostics: What Changes in the Indian Laboratory

Quick Answer Digital pathology replaces the glass slide and microscope with a scanned digital image viewed and reported on a screen — enabling remote sign-out, easier consultation, and integration with AI-assisted image analysis tools. In Indian laboratories, the practical changes are showing up in three areas: reporting workflow (screen-based review, digital annotation, remote second opinions), quality assurance (new validation requirements before clinical deployment), and turnaround time (faster in some workflows, unchanged or slower in others during the transition period). AI tools currently assist with specific, narrow tasks — quantification, screening triage, pattern flagging — rather than replacing pathologist judgment on final diagnosis. Digital pathology has been discussed as an imminent transformation for over a decade. What has actually changed in Indian laboratory practice is more incremental and more specific than the broader “AI will transform pathology” framing suggests. This article sets aside the hype and looks at what digital pathology and AI-assisted diagnostics concretely alter for a working pathologist — in reporting workflow, quality assurance, and turnaround time — and what remains unchanged. This is a technology-and-practice piece, not a career guide. For pathology subspecialty and career pathway content, see our comparison of Fellowship in Molecular Pathology vs Cytopathology, and MGA’s Fellowship in Pathology for the foundational program. Growing India’s digital pathology adoption, per market analysts Scanners Largest segment of India’s digital pathology market Narrow AI Current role: quantification & triage, not diagnosis Market growth figures for India’s digital pathology sector vary substantially across research providers depending on methodology and market definition; directional growth is consistently reported, though we avoid citing a single disputed figure here. What this article covers What digital pathology actually is — and is not What changes in reporting workflow Where AI-assisted diagnostics genuinely help today Where AI does not replace pathologist judgment Telepathology and remote reporting in the Indian context Quality assurance and validation implications Turnaround time: what actually speeds up, what doesn’t What this means for pathologist skill requirements Frequently asked questions What digital pathology actually is — and is not Digital pathology, at its core, is the digitisation of the glass slide. A whole slide imaging (WSI) scanner captures a high-resolution digital image of the entire slide, which the pathologist then views, annotates, and reports on a computer screen rather than through a microscope eyepiece. The digital image can be stored, transmitted, shared for consultation, and — where validated systems are in place — analysed by computational tools. It is worth being precise about what this is not. Digital pathology is not, by itself, a diagnostic method — it is an image acquisition and viewing method. The diagnostic reasoning remains the pathologist’s, whether performed on glass or on screen. AI-assisted diagnostics is a separate, additional layer that can be built on top of digitised images — but digitisation and AI analysis are not the same thing, and a laboratory can digitise its workflow without deploying any AI tools at all. In India, scanner devices currently represent the largest single segment of digital pathology market activity, reflecting where laboratories are actually investing — in the acquisition and viewing infrastructure — ahead of widespread AI deployment. Institutions such as KIMS Odisha have publicly commissioned whole slide scanning systems as part of routine cancer diagnosis workflows, illustrating the practical, incremental nature of adoption rather than a wholesale technology replacement. What changes in reporting workflow Screen-based sign-out replaces the microscope for primary review The most direct workflow change is that primary diagnostic review shifts from eyepiece to screen. This changes ergonomics, requires monitor calibration standards to preserve colour and detail fidelity, and requires a different visual scanning discipline — moving across a digital slide is not identical to moving a physical slide under a microscope, and pathologists transitioning to digital sign-out typically undergo a validation period comparing their digital and glass-slide diagnostic concordance before full digital transition. Digital annotation and case marking Digital slides allow annotation tools — marking regions of interest, measuring dimensions directly on the image, and flagging areas for a colleague’s review — that are more precise and shareable than physical slide marking. This is a genuine workflow improvement for teaching, multidisciplinary case review, and documentation. Remote consultation and second opinions Perhaps the most immediately valuable change: a digitised slide can be shared instantly with a specialist anywhere, without physically shipping the glass slide. For a complex or unusual case requiring subspecialty input, this collapses what was previously a multi-day courier process into a same-day digital consultation. This capability underpins much of the telepathology discussion in the Indian context (covered below). Integration with laboratory information systems Digital pathology platforms increasingly integrate with laboratory information systems (LIS), linking the digital image directly to the patient record, prior reports, and relevant clinical data — reducing the manual cross-referencing that glass-slide workflows require. Where AI-assisted diagnostics genuinely help today The realistic, current-state role of AI in pathology is narrow and task-specific — not the general diagnostic replacement that popular framing sometimes suggests. The applications with genuine, demonstrated value fall into a few defined categories. Quantification tasks Counting mitotic figures, quantifying Ki-67 proliferation index, and measuring immunohistochemistry staining intensity are tasks that are time-consuming and subject to inter-observer variability when performed manually. AI-assisted quantification tools perform these specific counting and measurement tasks with good reproducibility, and are among the most mature and clinically adopted AI applications in pathology internationally. Screening and triage in high-volume cytology In cervical cytology screening, AI-assisted pre-screening can flag slides most likely to contain abnormal cells for prioritised pathologist review — a triage function that helps manage high case volumes rather than a diagnostic replacement. The pathologist still makes the final diagnostic call on flagged and unflagged material according to laboratory protocol. Pattern detection as a second check AI tools trained to flag specific patterns — certain tumour morphologies, particular infectious organisms, specific staining patterns — can serve as a second-check overlay, similar in concept to spell-check: a prompt for the pathologist to look again at a specific region, not a replacement diagnosis.

Scroll to Top